RecruitingNCT01372800

Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases

Serum Adiponectin Concentration, Activity and Isoforms in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases

Sponsor

Xijing Hospital

Enrollment

30,000 participants

Start Date

May 1, 2011

Study Type

OBSERVATIONAL

Conditions

Myocardial Infarction Cerebral Infarction

Summary

Adiponectin (Ad) is an abundant protein in human body, and reports have shown that it act as a novel risk factor for brain and heart ischemia injury. This 5 years follow-up study will focus on serum adiponectin concentration, activity and isoforms in Chinese population and its correlation to these diseases.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria1

available for 5 years of follow-up study

Exclusion Criteria7

Death caused other than cardiovascular and cerebralvascular diseases till the study ends
Floating Population
Pregnancy, lactation, or child bearing women
Tumor
Active hepatic disease or hepatic dysfunction, or AST/ALT > 1.5UNL
Severe renal dysfunction(Scr > 3 mg/dl or 264μmol/L)
Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding

Interested in this trial?

Get notified about updates and connect with the research team.